SIG — Sigma Healthcare Cashflow Statement
0.000.00%
- AU$33.12bn
- AU$35.05bn
- AU$4.93bn
- 71
- 15
- 70
- 53
Annual cashflow statement for Sigma Healthcare, fiscal year end - January 31st, AUD millions except per share, conversion factor applied.
C2021 January 31st | 2022 January 31st | C2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.361 | 0.221 | 0.597 | 1.69 | 8.04 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -13.1 | -46.3 | 136 | 42 | -316 |
| Capital Expenditures | -51.4 | -14.2 | -29.4 | -4.72 | -7.91 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 176 | -2.39 | 0.795 | 10.5 | 6.31 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 124 | -16.6 | -28.6 | 5.73 | -1.6 |
| Financing Cash Flow Items | -1.59 | 0 | -0.98 | -0.809 | -1.35 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -266 | 129 | -110 | 296 | -24.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -154 | 66 | -2.8 | 344 | -342 |